NOTE: We are upgrading our eBook operations; please allow up to 1-2 days for delivery of your eBook order.
»
Advances in Cancer Research
 
 

Advances in Cancer Research, 1st Edition

 
Advances in Cancer Research, 1st Edition,Paul Fisher,Kenneth Tew,ISBN9780123942807
 
 
 

Fisher   &   Tew   

Academic Press

9780123942807

9780123978417

304

229 X 152

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.

Print Book + eBook

USD 202.20
USD 337.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 171.00

eBook
eBook Overview

DRM Free included formats: EPub, Mobi, PDF

USD 166.00
Add to Cart
 
 

Key Features

  • 113th volume of Advances in Cancer Research
  • Expert authors
  • Chapters on topics including microRNA regulatory network, multifaceted oncoprotein tax, and underlying chromosomal translocations

Description

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.

Readership

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.

Kenneth Tew

Professor & Chairman, Dept of Cell & Molecular Pharmacology John C. West Chair of Cancer Research, Medical University of South Carolina, USA The Tew laboratory maintains an interest in using redox pathways as a platform to develop therapeutic strategies through drug discovery/development and biomarker identification. We interrogate how reactive oxygen and nitrogen species (ROS/RNS) impact cancer cells and develop novel drugs that impact on glutathione based pathways. Our research efforts have been integral to studies that have identified glutathione S-transferases (GST) as important in drug resistance, catalytic detoxification and as arbiters of kinase-mediated cell signaling events. In addition, we have been instrumental in defining how GSTP contributes to the process by which cells respond to ROS by selective addition of glutathione to specific protein clusters, so called S-glutathionylation. Each of these research areas has had broad impact on a number of cancer disciplines. Moreover, we have also been seminally involved in the Phase I to III clinical testing of three oncology drugs, Telcyta, Telintra and NOV-002. Other ongoing translational efforts have produced two ongoing clinical trials to measure the effectiveness of serum S-glutathionylated serine proteinase inhibitors as possible biomarkers for exposure to hydrogen peroxide mouthwashes and radiation.

Affiliations and Expertise

Deptartment of Cell & Molecular Pharmacology, Medical University of South Carolina, USA

Advances in Cancer Research, 1st Edition

      1. The AID dilemma: infection, or cancer?
      2. Tasuku Honjo, Maki Kobayashi, Nasim Begum, Ai Kotani, Somayeh Sabouri, and Hitoshi Nagaoka

      3. The microRNA regulatory network in normal- and HTLV-1-transformed T cells
      4. Donna M. D’Agostino, Paola Zanovello, Toshiki Watanabe and Vincenzo Climinale

      5. The multifaceted oncoprotein Tax: Sub-cellular localization, post-translational modifications and NF-?B activation
      6. Youmna Kfoury, Rihab Nasr, Chloé Journo, Renaud Mahieux, Claudine Pique and Ali Bazarbachi

      7. Lynch or not Lynch? Is that always a question?
      8. Chrystelle Colas, Florence Coulet, Magali Svrcek, Ada Collura, Jean-François Fléjou, Alex Duval and Richard Hamelin

      9. Activation induced deaminase in antibody diversification and chromosome translocation
      10. Anna Gazumyan, Anne Bothmer, Isaac A. Klein, Michel C Nussenzweig and Kevin M. McBride

      11. Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed
      12. Li Qin, Jennifer L. Bromberg-White, and Chao-Nan Qian

      13. Molecular Logic Underlying Chromosomal Translocations, Random or non-Random?

      Chunru Lin, Liuqing Yang and Michael G. Rosenfeld

 

Quotes and reviews

Praise for the Serial:
"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences."-- American Scientist
"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced."-- Journal of Medicinal Chemistry
"This is a series that has a long tradition of excellence in the field of cancer biology."-- Doody's Publishing Reviews
 
 
Discount on Science and Technology eBooks | Use code DRMFREE
NOTE: We are upgrading our eBook operations; please allow up to 1-2 days for delivery of your eBook order.